Companies: 49,246 Total Market Cap: 132596284745423.86

PharmaEngine

TPEX-4162

Healthcare Biotechnology

Rank #14496

Market Cap 439.73 M

Volume 617,304

Price 3.06

Change (%) 1.09%

Country or region

Taiwan

PharmaEngine's latest marketcap:

439.73 M

As of 05/20/2025, PharmaEngine's market capitalization has reached $439.73 M. According to our data, PharmaEngine is the 14496th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	439.73 M
Revenue (ttm)	84.34 M
Net Income (ttm)	58.68 M
Shares Out	143.68 M
EPS (ttm)	0.41
Forward PE	29.47
Ex-Dividend Date	08/12/2024
Earnings Date	04/30/2025

Market Cap Chart

Data Updated: 05/20/2025

PharmaEngine's yearly market capitalization.

PharmaEngine has seen its market value grow from NT$8.43 B to NT$13.28 B since 2020, representing a total increase of 57.48% and an annual compound growth rate (CAGR) of 10.91%.

Date	Market Cap	Change (%)
05/20/2025	NT$13.28 B	0.22%
12/31/2024	NT$12.97 B	-14.41%
12/29/2023	NT$15.16 B	-15.6%
12/30/2022	NT$17.96 B	75.96%
12/30/2021	NT$10.21 B	21.08%
12/31/2020	NT$8.43 B

Company Profile

About PharmaEngine, Inc.

PharmaEngine, Inc. is a biopharmaceutical company focused on developing innovative drugs for cancer treatment. Headquartered in Taipei, Taiwan, the company was established in 2002 and specializes in oncology therapeutics.

Key Products and Developments

ONIVYDE: A cancer medicine that inhibits topoisomerase I, an enzyme critical for DNA replication in cancer cells.
PEP07: A CHK1 inhibitor currently in Phase 1 clinical trials for treating hematological and solid tumors.

PharmaEngine is committed to advancing cancer therapies through cutting-edge research and clinical development.

Frequently Asked Questions

As of 05/20/2025, PharmaEngine (including the parent company, if applicable) has an estimated market capitalization of $439.73 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

PharmaEngine global market capitalization ranking is approximately 14496 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Taiwan
Founded	2002
IPO Date	n/a
Employees	44
CEO	Hong-Ren Wang
Sector	Healthcare
Industry	Biotechnology
Address	10 Minsheng East Road Taipei, 104 Taiwan
Website	https://www.pharmaengine.com